Follicular Lymphoma Controled Clinical Trial with Integral Therapy In Untreated Patients
1. Abstract Follicular lymphoma (FL) is the second most frequent non-Hodg kin lymphoma, and until now the best treatment has not been de fined, most studies show an excelent Overal Survival (OS), but relapse is observed at very short time. Thus, actually the goal of most studies is to Increase Progression-free survival (PFS).
Follicular Lymphoma Controled Clinical Trial with Integral Therapy In Untreated Patients Read More »
